Condition: Dementia · Sponsor: Assistance Publique - Hôpitaux de Paris
The CIRCAME study is a bicentric study of patients from 2 memory clinics in Paris. The main objective is to identify circadian rhythm components and other individual risk factors (sociodemographic, behavioral, and health related factors) associated with the diagnosis of subtypes (AD, Lewy bodies, vascular, frontotemporal dementia) and stages (cognitively healthy, mild cognitive impairment, clinical dementia) of dementia, independent of known risk factors (sociodemographic and genetic) and assess the relevance of use of these factors in primary care for screen of dementia including subtypes and stages. A secondary objective is to determine factors associated with progression of the disease, in terms of cognitive decline and limitations in activities of daily living, as well as progression to dementia among cognitively healthy controls and patients with mild cognitive impairment, up to 15 years after the inclusion period.
This description comes directly from the study's public registry record.
Claire PAQUET, MDPhD · 0140054313 · claire.paquet@aphp.fr
Séverine SABIA, PhD · 0157279046 · severine.sabia@inserm.fr
Always discuss trial participation with your own doctor first.
| Centre de neurologie Cognitive / CMRR | Paris, France, France | Recruiting |
| Hôpital de Jour Gériatrique et consultation mémoire | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05977712